⌘K

Home/Filings/4/0001209191-22-004460

4//SEC Filing

KENNEY CHRISTOPHER JOHN 4

Accession 0001209191-22-004460

CIK 0001582313other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:04 PM ET

Size

4.5 KB

Accession

0001209191-22-004460

Insider Transaction Report

Form 4

Period: 2022-01-21

Xenon Pharmaceuticals Inc.XENE

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

Transactions

Purchase
Common Shares
2022-01-21$28.81/sh+700$20,167→ 700 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1

filerCIK 0001880129

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 5:04 PM ET
Size: 4.5 KB

View on SEC.gov